Quinoline- and Isoindoline-Integrated Polycyclic Compounds as Antioxidant, and Antidiabetic Agents Targeting the Dual Inhibition of α-Glycosidase and α-Amylase Enzymes Article Swipe
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.3390/ph16091222
Novel analogs of quinoline and isoindoline containing various heterocycles, such as tetrazole, triazole, pyrazole, and pyridine, were synthesized and characterized using FT-IR, NMR, and mass spectroscopy, and their antioxidant and antidiabetic activities were investigated. The previously synthesized compound 1 was utilized in conjugation with ketone-bearing tetrazole and isoindoline-1,3-dione to synthesize Schiff’s bases 2 and 3. Furthermore, hydrazide 1 was treated with aryledines to provide pyrazoles 4a–c. Compound 5 was obtained by treating 1 with potassium thiocyanate, which was then cyclized in a basic solution to afford triazole 6. On the other hand, pyridine derivatives 7a–d and 8a–d were synthesized using 2-(4-acetylphenyl)isoindoline-1,3-dione via a one-pot condensation reaction with aryl aldehydes and active methylene compounds. From the antioxidant and antidiabetic studies, compound 7d showed significant antioxidant activity with an EC50 = 0.65, 0.52, and 0.93 mM in the free radical scavenging assays (DPPH, ABTS, and superoxide anion radicals). It also displayed noteworthy inhibitory activity against both enzymes α-glycosidase (IC50: 0.07 mM) and α-amylase (0.21 mM) compared to acarbose (0.09 mM α-glycosidase and 0.25 mM for α-amylase), and higher than in the other compounds. During in silico assays, compound 7d exhibited favorable binding affinities towards both α-glycosidase (−10.9 kcal/mol) and α-amylase (−9.0 kcal/mol) compared to acarbose (−8.6 kcal/mol for α-glycosidase and −6.0 kcal/mol for α-amylase). The stability of 7d was demonstrated by molecular dynamics simulations and estimations of the binding free energy throughout the simulation session (100 ns).
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.3390/ph16091222
- https://www.mdpi.com/1424-8247/16/9/1222/pdf?version=1693364639
- OA Status
- gold
- Cited By
- 13
- References
- 83
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4386284233
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4386284233Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.3390/ph16091222Digital Object Identifier
- Title
-
Quinoline- and Isoindoline-Integrated Polycyclic Compounds as Antioxidant, and Antidiabetic Agents Targeting the Dual Inhibition of α-Glycosidase and α-Amylase EnzymesWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-08-30Full publication date if available
- Authors
-
Mohammed Al‐Ghorbani, Osama Alharbi, Abdel-Basit Al-Odayni, Naaser A. Y. AbduhList of authors in order
- Landing page
-
https://doi.org/10.3390/ph16091222Publisher landing page
- PDF URL
-
https://www.mdpi.com/1424-8247/16/9/1222/pdf?version=1693364639Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.mdpi.com/1424-8247/16/9/1222/pdf?version=1693364639Direct OA link when available
- Concepts
-
Chemistry, Isoindoline, ABTS, Quinoline, Stereochemistry, Antioxidant, Tetrazole, Combinatorial chemistry, DPPH, Organic chemistryTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
13Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 4, 2024: 8, 2023: 1Per-year citation counts (last 5 years)
- References (count)
-
83Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4386284233 |
|---|---|
| doi | https://doi.org/10.3390/ph16091222 |
| ids.doi | https://doi.org/10.3390/ph16091222 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/37765030 |
| ids.openalex | https://openalex.org/W4386284233 |
| fwci | 2.50732409 |
| type | article |
| title | Quinoline- and Isoindoline-Integrated Polycyclic Compounds as Antioxidant, and Antidiabetic Agents Targeting the Dual Inhibition of α-Glycosidase and α-Amylase Enzymes |
| biblio.issue | 9 |
| biblio.volume | 16 |
| biblio.last_page | 1222 |
| biblio.first_page | 1222 |
| topics[0].id | https://openalex.org/T10274 |
| topics[0].field.id | https://openalex.org/fields/16 |
| topics[0].field.display_name | Chemistry |
| topics[0].score | 0.9997000098228455 |
| topics[0].domain.id | https://openalex.org/domains/3 |
| topics[0].domain.display_name | Physical Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1605 |
| topics[0].subfield.display_name | Organic Chemistry |
| topics[0].display_name | Synthesis and biological activity |
| topics[1].id | https://openalex.org/T12412 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9987000226974487 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | Enzyme function and inhibition |
| topics[2].id | https://openalex.org/T13160 |
| topics[2].field.id | https://openalex.org/fields/16 |
| topics[2].field.display_name | Chemistry |
| topics[2].score | 0.9959999918937683 |
| topics[2].domain.id | https://openalex.org/domains/3 |
| topics[2].domain.display_name | Physical Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1605 |
| topics[2].subfield.display_name | Organic Chemistry |
| topics[2].display_name | Synthesis and Biological Evaluation |
| is_xpac | False |
| apc_list.value | 2000 |
| apc_list.currency | CHF |
| apc_list.value_usd | 2165 |
| apc_paid.value | 2000 |
| apc_paid.currency | CHF |
| apc_paid.value_usd | 2165 |
| concepts[0].id | https://openalex.org/C185592680 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8987602591514587 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[0].display_name | Chemistry |
| concepts[1].id | https://openalex.org/C2777778190 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6122170686721802 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q2598923 |
| concepts[1].display_name | Isoindoline |
| concepts[2].id | https://openalex.org/C2781031786 |
| concepts[2].level | 4 |
| concepts[2].score | 0.6033974289894104 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q287582 |
| concepts[2].display_name | ABTS |
| concepts[3].id | https://openalex.org/C2776309666 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5666589140892029 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q408384 |
| concepts[3].display_name | Quinoline |
| concepts[4].id | https://openalex.org/C71240020 |
| concepts[4].level | 1 |
| concepts[4].score | 0.43806812167167664 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q186011 |
| concepts[4].display_name | Stereochemistry |
| concepts[5].id | https://openalex.org/C2778004101 |
| concepts[5].level | 2 |
| concepts[5].score | 0.43027475476264954 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q133948 |
| concepts[5].display_name | Antioxidant |
| concepts[6].id | https://openalex.org/C2780827033 |
| concepts[6].level | 2 |
| concepts[6].score | 0.42480459809303284 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q58826308 |
| concepts[6].display_name | Tetrazole |
| concepts[7].id | https://openalex.org/C21951064 |
| concepts[7].level | 1 |
| concepts[7].score | 0.39138734340667725 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q899212 |
| concepts[7].display_name | Combinatorial chemistry |
| concepts[8].id | https://openalex.org/C2781401929 |
| concepts[8].level | 3 |
| concepts[8].score | 0.36267292499542236 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q5205953 |
| concepts[8].display_name | DPPH |
| concepts[9].id | https://openalex.org/C178790620 |
| concepts[9].level | 1 |
| concepts[9].score | 0.2950991690158844 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q11351 |
| concepts[9].display_name | Organic chemistry |
| keywords[0].id | https://openalex.org/keywords/chemistry |
| keywords[0].score | 0.8987602591514587 |
| keywords[0].display_name | Chemistry |
| keywords[1].id | https://openalex.org/keywords/isoindoline |
| keywords[1].score | 0.6122170686721802 |
| keywords[1].display_name | Isoindoline |
| keywords[2].id | https://openalex.org/keywords/abts |
| keywords[2].score | 0.6033974289894104 |
| keywords[2].display_name | ABTS |
| keywords[3].id | https://openalex.org/keywords/quinoline |
| keywords[3].score | 0.5666589140892029 |
| keywords[3].display_name | Quinoline |
| keywords[4].id | https://openalex.org/keywords/stereochemistry |
| keywords[4].score | 0.43806812167167664 |
| keywords[4].display_name | Stereochemistry |
| keywords[5].id | https://openalex.org/keywords/antioxidant |
| keywords[5].score | 0.43027475476264954 |
| keywords[5].display_name | Antioxidant |
| keywords[6].id | https://openalex.org/keywords/tetrazole |
| keywords[6].score | 0.42480459809303284 |
| keywords[6].display_name | Tetrazole |
| keywords[7].id | https://openalex.org/keywords/combinatorial-chemistry |
| keywords[7].score | 0.39138734340667725 |
| keywords[7].display_name | Combinatorial chemistry |
| keywords[8].id | https://openalex.org/keywords/dpph |
| keywords[8].score | 0.36267292499542236 |
| keywords[8].display_name | DPPH |
| keywords[9].id | https://openalex.org/keywords/organic-chemistry |
| keywords[9].score | 0.2950991690158844 |
| keywords[9].display_name | Organic chemistry |
| language | en |
| locations[0].id | doi:10.3390/ph16091222 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S16322639 |
| locations[0].source.issn | 1424-8247 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1424-8247 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Pharmaceuticals |
| locations[0].source.host_organization | https://openalex.org/P4310310987 |
| locations[0].source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310310987 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.mdpi.com/1424-8247/16/9/1222/pdf?version=1693364639 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Pharmaceuticals |
| locations[0].landing_page_url | https://doi.org/10.3390/ph16091222 |
| locations[1].id | pmid:37765030 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Pharmaceuticals (Basel, Switzerland) |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/37765030 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:10535292 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by |
| locations[2].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10535292/pdf/pharmaceuticals-16-01222.pdf |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Pharmaceuticals (Basel) |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10535292 |
| locations[3].id | pmh:oai:mdpi.com:/1424-8247/16/9/1222/ |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306400947 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | True |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | MDPI (MDPI AG) |
| locations[3].source.host_organization | https://openalex.org/I4210097602 |
| locations[3].source.host_organization_name | Multidisciplinary Digital Publishing Institute (Switzerland) |
| locations[3].source.host_organization_lineage | https://openalex.org/I4210097602 |
| locations[3].license | cc-by |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/cc-by |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Pharmaceuticals |
| locations[3].landing_page_url | https://dx.doi.org/10.3390/ph16091222 |
| locations[4].id | pmh:oai:doaj.org/article:2810d822976c48b4b3a1423b1bfc7dae |
| locations[4].is_oa | False |
| locations[4].source.id | https://openalex.org/S4306401280 |
| locations[4].source.issn | |
| locations[4].source.type | repository |
| locations[4].source.is_oa | False |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[4].source.host_organization | |
| locations[4].source.host_organization_name | |
| locations[4].source.host_organization_lineage | |
| locations[4].license | |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | article |
| locations[4].license_id | |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | Pharmaceuticals, Vol 16, Iss 9, p 1222 (2023) |
| locations[4].landing_page_url | https://doaj.org/article/2810d822976c48b4b3a1423b1bfc7dae |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5047801145 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-9079-5788 |
| authorships[0].author.display_name | Mohammed Al‐Ghorbani |
| authorships[0].countries | SA |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I23075662 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Chemistry, College of Science and Arts, Ulla, Taibah University, Madinah 41477, Saudi Arabia |
| authorships[0].institutions[0].id | https://openalex.org/I23075662 |
| authorships[0].institutions[0].ror | https://ror.org/01xv1nn60 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I23075662 |
| authorships[0].institutions[0].country_code | SA |
| authorships[0].institutions[0].display_name | Taibah University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Mohammed Al-Ghorbani |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Department of Chemistry, College of Science and Arts, Ulla, Taibah University, Madinah 41477, Saudi Arabia |
| authorships[1].author.id | https://openalex.org/A5111341883 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-6513-5334 |
| authorships[1].author.display_name | Osama Alharbi |
| authorships[1].countries | SA |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I23075662 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Chemistry, College of Science and Arts, Ulla, Taibah University, Madinah 41477, Saudi Arabia |
| authorships[1].institutions[0].id | https://openalex.org/I23075662 |
| authorships[1].institutions[0].ror | https://ror.org/01xv1nn60 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I23075662 |
| authorships[1].institutions[0].country_code | SA |
| authorships[1].institutions[0].display_name | Taibah University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Osama Alharbi |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Chemistry, College of Science and Arts, Ulla, Taibah University, Madinah 41477, Saudi Arabia |
| authorships[2].author.id | https://openalex.org/A5073118751 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-7652-093X |
| authorships[2].author.display_name | Abdel-Basit Al-Odayni |
| authorships[2].countries | SA |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I28022161 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Restorative Dental Science, College of Dentistry, King Saud University, P.O. Box 60169, Riyadh 11545, Saudi Arabia |
| authorships[2].institutions[0].id | https://openalex.org/I28022161 |
| authorships[2].institutions[0].ror | https://ror.org/02f81g417 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I28022161 |
| authorships[2].institutions[0].country_code | SA |
| authorships[2].institutions[0].display_name | King Saud University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Abdel-Basit Al-Odayni |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Restorative Dental Science, College of Dentistry, King Saud University, P.O. Box 60169, Riyadh 11545, Saudi Arabia |
| authorships[3].author.id | https://openalex.org/A5021140694 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-7559-1760 |
| authorships[3].author.display_name | Naaser A. Y. Abduh |
| authorships[3].countries | SA |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I28022161 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Chemistry, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia |
| authorships[3].institutions[0].id | https://openalex.org/I28022161 |
| authorships[3].institutions[0].ror | https://ror.org/02f81g417 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I28022161 |
| authorships[3].institutions[0].country_code | SA |
| authorships[3].institutions[0].display_name | King Saud University |
| authorships[3].author_position | last |
| authorships[3].raw_author_name | Naaser A. Y. Abduh |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Chemistry, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.mdpi.com/1424-8247/16/9/1222/pdf?version=1693364639 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Quinoline- and Isoindoline-Integrated Polycyclic Compounds as Antioxidant, and Antidiabetic Agents Targeting the Dual Inhibition of α-Glycosidase and α-Amylase Enzymes |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10274 |
| primary_topic.field.id | https://openalex.org/fields/16 |
| primary_topic.field.display_name | Chemistry |
| primary_topic.score | 0.9997000098228455 |
| primary_topic.domain.id | https://openalex.org/domains/3 |
| primary_topic.domain.display_name | Physical Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1605 |
| primary_topic.subfield.display_name | Organic Chemistry |
| primary_topic.display_name | Synthesis and biological activity |
| related_works | https://openalex.org/W2035036423, https://openalex.org/W2736956326, https://openalex.org/W2950105892, https://openalex.org/W2188585130, https://openalex.org/W2378022668, https://openalex.org/W2992373132, https://openalex.org/W87133675, https://openalex.org/W3138492448, https://openalex.org/W2381026251, https://openalex.org/W2781240001 |
| cited_by_count | 13 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 4 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 8 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 1 |
| locations_count | 5 |
| best_oa_location.id | doi:10.3390/ph16091222 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S16322639 |
| best_oa_location.source.issn | 1424-8247 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1424-8247 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Pharmaceuticals |
| best_oa_location.source.host_organization | https://openalex.org/P4310310987 |
| best_oa_location.source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310310987 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.mdpi.com/1424-8247/16/9/1222/pdf?version=1693364639 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Pharmaceuticals |
| best_oa_location.landing_page_url | https://doi.org/10.3390/ph16091222 |
| primary_location.id | doi:10.3390/ph16091222 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S16322639 |
| primary_location.source.issn | 1424-8247 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1424-8247 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Pharmaceuticals |
| primary_location.source.host_organization | https://openalex.org/P4310310987 |
| primary_location.source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310310987 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.mdpi.com/1424-8247/16/9/1222/pdf?version=1693364639 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Pharmaceuticals |
| primary_location.landing_page_url | https://doi.org/10.3390/ph16091222 |
| publication_date | 2023-08-30 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W2886970149, https://openalex.org/W2255246778, https://openalex.org/W2910015638, https://openalex.org/W3198993724, https://openalex.org/W4281934055, https://openalex.org/W4318579820, https://openalex.org/W2101508556, https://openalex.org/W2121373279, https://openalex.org/W4283119088, https://openalex.org/W2089674988, https://openalex.org/W3182913738, https://openalex.org/W2525526318, https://openalex.org/W2898041522, https://openalex.org/W2279101401, https://openalex.org/W2200071945, https://openalex.org/W2033873838, https://openalex.org/W2920739685, https://openalex.org/W3093798158, https://openalex.org/W1969581664, https://openalex.org/W4221017639, https://openalex.org/W1983197743, https://openalex.org/W2018134892, https://openalex.org/W1981259610, https://openalex.org/W3126903533, https://openalex.org/W3011206779, https://openalex.org/W4283718726, https://openalex.org/W3091432201, https://openalex.org/W2950821684, https://openalex.org/W2152921144, https://openalex.org/W2952942957, https://openalex.org/W2951569785, https://openalex.org/W2258511069, https://openalex.org/W3035756013, https://openalex.org/W2572916045, https://openalex.org/W2040165368, https://openalex.org/W4379615050, https://openalex.org/W1979547872, https://openalex.org/W4367316217, https://openalex.org/W4323663380, https://openalex.org/W4320494392, https://openalex.org/W2000391072, https://openalex.org/W4220889058, https://openalex.org/W4285040069, https://openalex.org/W3198372247, https://openalex.org/W4297091174, https://openalex.org/W4362555802, https://openalex.org/W4285010474, https://openalex.org/W2901434370, https://openalex.org/W3199005256, https://openalex.org/W4200054594, https://openalex.org/W4385692813, https://openalex.org/W4387439282, https://openalex.org/W4294311555, https://openalex.org/W4312226260, https://openalex.org/W4319828751, https://openalex.org/W4304187392, https://openalex.org/W4308326590, https://openalex.org/W2104509445, https://openalex.org/W6688343070, https://openalex.org/W2308458222, https://openalex.org/W2517888724, https://openalex.org/W1513493564, https://openalex.org/W2991072874, https://openalex.org/W2613574096, https://openalex.org/W2885024660, https://openalex.org/W2001726712, https://openalex.org/W2054979333, https://openalex.org/W1885778179, https://openalex.org/W4296641975, https://openalex.org/W4293090477, https://openalex.org/W6788914129, https://openalex.org/W4221070434, https://openalex.org/W3195528664, https://openalex.org/W3202420089, https://openalex.org/W4291670245, https://openalex.org/W4225660083, https://openalex.org/W4205841222, https://openalex.org/W4224252043, https://openalex.org/W4385462668, https://openalex.org/W4291756461, https://openalex.org/W3121672928, https://openalex.org/W2209181457, https://openalex.org/W4317932658 |
| referenced_works_count | 83 |
| abstract_inverted_index.1 | 38, 57, 72 |
| abstract_inverted_index.2 | 52 |
| abstract_inverted_index.5 | 67 |
| abstract_inverted_index.= | 128 |
| abstract_inverted_index.a | 81, 102 |
| abstract_inverted_index.3. | 54 |
| abstract_inverted_index.6. | 87 |
| abstract_inverted_index.7d | 120, 186, 215 |
| abstract_inverted_index.It | 146 |
| abstract_inverted_index.On | 88 |
| abstract_inverted_index.an | 126 |
| abstract_inverted_index.as | 10 |
| abstract_inverted_index.by | 70, 218 |
| abstract_inverted_index.in | 41, 80, 134, 177, 182 |
| abstract_inverted_index.mM | 133, 167, 171 |
| abstract_inverted_index.of | 2, 214, 224 |
| abstract_inverted_index.to | 48, 62, 84, 164, 201 |
| abstract_inverted_index.The | 34, 212 |
| abstract_inverted_index.and | 4, 14, 18, 23, 26, 29, 46, 53, 95, 109, 116, 131, 142, 159, 169, 174, 196, 207, 222 |
| abstract_inverted_index.for | 172, 205, 210 |
| abstract_inverted_index.mM) | 158, 162 |
| abstract_inverted_index.the | 89, 114, 135, 178, 225, 230 |
| abstract_inverted_index.via | 101 |
| abstract_inverted_index.was | 39, 58, 68, 77, 216 |
| abstract_inverted_index.(100 | 233 |
| abstract_inverted_index.0.07 | 157 |
| abstract_inverted_index.0.25 | 170 |
| abstract_inverted_index.0.93 | 132 |
| abstract_inverted_index.EC50 | 127 |
| abstract_inverted_index.From | 113 |
| abstract_inverted_index.NMR, | 22 |
| abstract_inverted_index.also | 147 |
| abstract_inverted_index.aryl | 107 |
| abstract_inverted_index.both | 153, 192 |
| abstract_inverted_index.free | 136, 227 |
| abstract_inverted_index.mass | 24 |
| abstract_inverted_index.ns). | 234 |
| abstract_inverted_index.such | 9 |
| abstract_inverted_index.than | 176 |
| abstract_inverted_index.then | 78 |
| abstract_inverted_index.were | 16, 32, 97 |
| abstract_inverted_index.with | 43, 60, 73, 106, 125 |
| abstract_inverted_index.(0.09 | 166 |
| abstract_inverted_index.(0.21 | 161 |
| abstract_inverted_index.0.52, | 130 |
| abstract_inverted_index.0.65, | 129 |
| abstract_inverted_index.ABTS, | 141 |
| abstract_inverted_index.Novel | 0 |
| abstract_inverted_index.anion | 144 |
| abstract_inverted_index.bases | 51 |
| abstract_inverted_index.basic | 82 |
| abstract_inverted_index.hand, | 91 |
| abstract_inverted_index.other | 90, 179 |
| abstract_inverted_index.their | 27 |
| abstract_inverted_index.using | 20, 99 |
| abstract_inverted_index.which | 76 |
| abstract_inverted_index.(DPPH, | 140 |
| abstract_inverted_index.(IC50: | 156 |
| abstract_inverted_index.7a–d | 94 |
| abstract_inverted_index.8a–d | 96 |
| abstract_inverted_index.During | 181 |
| abstract_inverted_index.FT-IR, | 21 |
| abstract_inverted_index.active | 110 |
| abstract_inverted_index.afford | 85 |
| abstract_inverted_index.assays | 139 |
| abstract_inverted_index.energy | 228 |
| abstract_inverted_index.higher | 175 |
| abstract_inverted_index.showed | 121 |
| abstract_inverted_index.silico | 183 |
| abstract_inverted_index.−6.0 | 208 |
| abstract_inverted_index.(−8.6 | 203 |
| abstract_inverted_index.(−9.0 | 198 |
| abstract_inverted_index.4a–c. | 65 |
| abstract_inverted_index.against | 152 |
| abstract_inverted_index.analogs | 1 |
| abstract_inverted_index.assays, | 184 |
| abstract_inverted_index.binding | 189, 226 |
| abstract_inverted_index.enzymes | 154 |
| abstract_inverted_index.one-pot | 103 |
| abstract_inverted_index.provide | 63 |
| abstract_inverted_index.radical | 137 |
| abstract_inverted_index.session | 232 |
| abstract_inverted_index.towards | 191 |
| abstract_inverted_index.treated | 59 |
| abstract_inverted_index.various | 7 |
| abstract_inverted_index.(−10.9 | 194 |
| abstract_inverted_index.Compound | 66 |
| abstract_inverted_index.acarbose | 165, 202 |
| abstract_inverted_index.activity | 124, 151 |
| abstract_inverted_index.compared | 163, 200 |
| abstract_inverted_index.compound | 37, 119, 185 |
| abstract_inverted_index.cyclized | 79 |
| abstract_inverted_index.dynamics | 220 |
| abstract_inverted_index.kcal/mol | 204, 209 |
| abstract_inverted_index.obtained | 69 |
| abstract_inverted_index.pyridine | 92 |
| abstract_inverted_index.reaction | 105 |
| abstract_inverted_index.solution | 83 |
| abstract_inverted_index.studies, | 118 |
| abstract_inverted_index.treating | 71 |
| abstract_inverted_index.triazole | 86 |
| abstract_inverted_index.utilized | 40 |
| abstract_inverted_index.aldehydes | 108 |
| abstract_inverted_index.displayed | 148 |
| abstract_inverted_index.exhibited | 187 |
| abstract_inverted_index.favorable | 188 |
| abstract_inverted_index.hydrazide | 56 |
| abstract_inverted_index.kcal/mol) | 195, 199 |
| abstract_inverted_index.methylene | 111 |
| abstract_inverted_index.molecular | 219 |
| abstract_inverted_index.potassium | 74 |
| abstract_inverted_index.pyrazole, | 13 |
| abstract_inverted_index.pyrazoles | 64 |
| abstract_inverted_index.pyridine, | 15 |
| abstract_inverted_index.quinoline | 3 |
| abstract_inverted_index.stability | 213 |
| abstract_inverted_index.tetrazole | 45 |
| abstract_inverted_index.triazole, | 12 |
| abstract_inverted_index.Schiff’s | 50 |
| abstract_inverted_index.activities | 31 |
| abstract_inverted_index.affinities | 190 |
| abstract_inverted_index.aryledines | 61 |
| abstract_inverted_index.compounds. | 112, 180 |
| abstract_inverted_index.containing | 6 |
| abstract_inverted_index.inhibitory | 150 |
| abstract_inverted_index.noteworthy | 149 |
| abstract_inverted_index.previously | 35 |
| abstract_inverted_index.radicals). | 145 |
| abstract_inverted_index.scavenging | 138 |
| abstract_inverted_index.simulation | 231 |
| abstract_inverted_index.superoxide | 143 |
| abstract_inverted_index.synthesize | 49 |
| abstract_inverted_index.tetrazole, | 11 |
| abstract_inverted_index.throughout | 229 |
| abstract_inverted_index.α-amylase | 160, 197 |
| abstract_inverted_index.antioxidant | 28, 115, 123 |
| abstract_inverted_index.conjugation | 42 |
| abstract_inverted_index.derivatives | 93 |
| abstract_inverted_index.estimations | 223 |
| abstract_inverted_index.isoindoline | 5 |
| abstract_inverted_index.significant | 122 |
| abstract_inverted_index.simulations | 221 |
| abstract_inverted_index.synthesized | 17, 36, 98 |
| abstract_inverted_index.Furthermore, | 55 |
| abstract_inverted_index.antidiabetic | 30, 117 |
| abstract_inverted_index.condensation | 104 |
| abstract_inverted_index.demonstrated | 217 |
| abstract_inverted_index.thiocyanate, | 75 |
| abstract_inverted_index.α-amylase), | 173 |
| abstract_inverted_index.α-amylase). | 211 |
| abstract_inverted_index.characterized | 19 |
| abstract_inverted_index.heterocycles, | 8 |
| abstract_inverted_index.investigated. | 33 |
| abstract_inverted_index.spectroscopy, | 25 |
| abstract_inverted_index.ketone-bearing | 44 |
| abstract_inverted_index.α-glycosidase | 155, 168, 193, 206 |
| abstract_inverted_index.isoindoline-1,3-dione | 47 |
| abstract_inverted_index.2-(4-acetylphenyl)isoindoline-1,3-dione | 100 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5047801145 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 4 |
| corresponding_institution_ids | https://openalex.org/I23075662 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/6 |
| sustainable_development_goals[0].score | 0.550000011920929 |
| sustainable_development_goals[0].display_name | Clean water and sanitation |
| citation_normalized_percentile.value | 0.8777445 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |